** Shares of regional lender Bank OZK OZK.O drop 8.3% to
$42.36 premarket
** Citigroup double downgrades stock to "sell" from "buy" on
concerns with OZK's projects, and its life science construction
lending in general
** Co's Research and Development District project in San
Diego has been tenant-less for four years as sizeable
pharmaceuticals rejected it due to location, indicative of
difficult life science construction lending market - Citi
** Believes OZK's Atlanta project to be its biggest
individual loan totaling $915 mln; loan likely to see some
deterioration in coming quarters as lackluster location and
large-scale leases drive lack of interest in office leasing
** Citi cuts PT on stock to $37 from $57; new PT a downside
of about 20% to last close
** Four brokerages maintain "buy" or higher rating, five
rate it "hold" and one "sell"; median PT at $49.50 - LSEG data
** Stock down 7.3% YTD, as of last close
(Reporting by Purvi Agarwal in Bengaluru)
((Purvi.Agarwal@thomsonreuters.com))